Generic Name and Formulations:
Progesterone (micronized) 100mg; vaginal insert.
Ferring Pharmaceuticals, Inc.
Indications for ENDOMETRIN:
To support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.
100mg vaginally 2 or 3 times daily starting at oocyte retrieval for up to 10 weeks total duration. ≥35yrs: efficacy not clearly established; see literature.
Breast carcinoma. Liver dysfunction or disease. Missed abortion. Ectopic pregnancy. Thrombophlebitis or thromboembolic disorders.
Depression. Discontinue if signs of thrombotic disorders (eg, thrombophlebitis, cerebrovascular disorders, pulmonary embolism, retinal thrombosis) occur. Pregnancy outcome: see literature. Nursing mothers.
Concomitant other vaginal products (eg, antifungals): not recommended.
GI upset, abdominal pain, post-oocyte retrieval pain, ovarian hyperstimulation syndrome, headache, uterine spasm, vaginal bleeding, fatigue, urinary tract infection.
Inserts—21 (w. applicators)
- 100mg inserts (Qty:21)
- appx. price $215.00
Sign Up for Free e-newsletters
- 2016 Recommended Immunization Schedule for Adults: What's Changed?
- First Sexually-Transmitted Zika Virus Case Confirmed in Texas
- 2016 Childhood and Adolescent Immunization Schedule Released
- Spiriva Respimat Gains Indication and New Dosage Strength
- To Rx or Not to Rx: Interventions to Improve Antibiotic Prescribing for Uncomplicated Acute RTI
- CDC Guidelines on Preventing Sexual Transmission of Zika Virus Issued
- CDC Updates Interim Zika Virus Guidelines for Pregnant Women and Women of Reproductive Age
- Daklinza Use Expanded to Cover Treatment in More HCV Patients
- Researchers Call for an Alternative Tdap Immunization Strategy for Adolescents
- FDA Announces Large Action Plan in Effort to Reverse the Opioid Epidemic